Search Results 61-70 of 17136 for egfr

1. Atezolizumab and hyaluronidase-tqjs (subcutaneous route) - Side effects & uses - Mayo Clinic

   ... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...

2. A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer - Mayo Clinic

   Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

3. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

   ... (eGFR > 60 mL/min/m2, BP<130/90 mmHg), and these correlate with defects in isolated endothelial cells. Participation eligibility. Participant eligibility ...

4. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

   Histologically or cytologically confirmed locally advanced or metastatic EGFRm+ NSCLC harbouring an EGFR mutation known to be associated with EGFR TKI ...

5. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

   To evaluate fresolimumab dose-dependent reduction in proteinuria; To compare the change in renal function (estimated glomerular filtration rate [eGFR]) in ...

6. A Study of Rociletinib (CO-1686) for Patients with a Mutant form of Non-Small Cell Lung Cancer. - Mayo Clinic

   To provide access to rociletinib for patients with advanced or metastatic EGFR-mutant NSCLC who have been treated previously with EGFR directed therapy and have ...

7. Researchers Use Genomic Sequencing to Help Identify New Therapies for Bile Duct Cancer - Mayo Clinic News Network

   Study targets EGFR and FGFR cellular pathways to treat rare disease. SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic's Center for ...

8. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

   The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express epidermal growth factor receptor (EGFR).

9. A Study to Detect Hyperkalemia Using Smartphone-enabled EKG - Mayo Clinic

   Ambulatory adult patients at increased risk for hyperkalemia due to age ≥ 50 years, and one or more criteria including eGFR (from serum creatinine) < 45 ml ...

10. Publications - Ramla N. Kasozi, M.B., Ch.B., M.P.H., FAAFP - Mayo Clinic

    Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation. Clin Chem. 2022 Mar 31; 68 (4):534-539. View PubMed. PST-20522797. Home; Publications ...